Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irofulven in Advanced Cervical Carcinoma
NCT00005070Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jan 2000
- Primary completion
- May 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of irofulven in Cervical Cancer (CC), sponsored by Memorial Sloan Kettering Cancer Center. Started Jan 2000; status: completed.
02
Drugs
irofulven
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00005070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005070.